AbbVie gets FDA approval for Parkinson’s disease drug Juvmo
Investing.com
2026-09-28T12:21:10Z
$264.34 (-0.29%)
Look this symbol up in Slack with /ticker ABBV. How to get stock tickers in Slack.
About AbbVie Inc
Healthcare
Loading chart…
Key Data
OPEN
$265.49
DAY RANGE
$262.59 - $266.0
52 WEEK RANGE
$189.4 - $269.39
MARKET CAP
$467119768000
VOLUME
2541718
AVERAGE VOLUME
Performance
Trade Day Range
$262.59
LOW
$266.0
HIGH
52 Week Range
$189.4
LOW
$269.39
HIGH
Trade Now
Using this link to sign up for Robinhood
Using this link to sign up for M1 Finance
Or this link to sign up for WeBull
Recent News
AbbVie's Once-Daily Parkinson's Pill Juvmo Wins FDA Approval, with Nausea, Dizziness, and Headache Common in Trials
Medical Daily
2026-09-28T10:40:47Z
AbbVie partners with IPO-bound Iambic for AI-led drug discoveries
Crain's Chicago Business
2026-09-28T10:14:51Z
AbbVie stock at USD 264.40 on September 25, 2026, down 0.27 percent
AD HOC NEWS
2026-09-28T05:41:26Z
This Cancer Drug Is Already Working. Now Its Nvidia-Backed Maker Is Going Public: Here’s What You Need to Know About Its IPO
Yahoo Finance
2026-09-27T18:41:47Z
Get ABBV quotes in Slack with /ticker ABBV.
